Effect of Simvastatin on Cardiac Hypertrophy in Rabbits with Chronic Heart Failure

齐洪涛,刘志华,蒋彬,邹操,赵彩明,李红霞,韩莲花,蒋庭波,宋建平,蒋文平

DOI: https://doi.org/10.19460/j.cnki.0253-3685.2010.04.025

2010-01-01

Abstract:Objective To study the effects of simvastatin on cardiac hypertrophy and cardiac function in rabbits with chronic congenital heart failure(CHF). Methods Twenty-four New Zealand rabbits were divided into 4 groups of A, B, C and D with 6 rabbits each. Group D underwent sham operation as healthy control. After establishment of CHF, the rabbits in group A were given oral simvastatin 5 mg· kg~(-1)·d~(-1) after the operation for 8 weeks, those in group B were given oral sirnvastatin 5 mg·kg~(-1) ·d~(-1) for 4 weeks started at 4 weeks after the operation,and those in group C were not given simvastatin as the controls. At the end of experiment, heart weight (HW), left ventricular weight (LVW), body weight (BW), heart weight/body weight radio (HW/BW radio), left ventricular weight/body weight radio (LVW/BW radio) were measured. Rho A expression in cardiomyocyte membrane was detected with Western blot. Rho GTPases activity was determined by [[γ~-~(32)P]]GTP- binding assay. Results Compared to groups of A and B, the HW, LVW, HW/BW radio,and LVW/BW radio were significantly higher and the IVSD, LVIDs, LVPWd and LVIDd were significantly increased in group C (P<0. 01, P<0.05). The EF and FS were significantly lower in CHF groups than those in group D (P<0. 01,P<0. 05). The expression of Rho A in cell membrane and the activity of Rho GTPase were significantly higher in group C than those in the other 3 groups (P<0. 01). Conclusion Simvastatin can inhibit cardiac hypertrophy and improve cardiac function by depressing the expression of Rho A in heart cell membrane and decreasing the activity of Rho GTPase in rabbits model with CHF.